US · BCTXZ
BriaCell Therapeutics Corp. Warrant
- Sector
- Healthcare · Biotechnology
- Headquarters
- West Vancouver, BC V7T 2X1
- Website
- briacell.com
Price · as of 2026-07-06
$0.09
Market cap 150.51K
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 |
USD millions
Line items
USD millions
Line items
USD millions
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| BCTXZ | BriaCell Therapeutics Cor… | $0.08 | 150.51K | — | — | — | — | — | — | — | — | — |
| AIMD | Ainos, Inc. | $2.74 | 12.41M | — | — | — | — | — | — | — | — | — |
| DRMA | Dermata Therapeutics, Inc… | $1.35 | 920.1K | — | — | — | — | -0.15 | 1.19 | — | 0.11 | — |
| ELAB | PMGC Holdings Inc. | $1.92 | 3.72M | — | — | — | +1,273,520% | — | — | — | — | — |
| MLEC | Moolec Science S.A. | $7.20 | 5.23M | +13,967% | +44,683,405% | — | — | -0.07 | -0.12 | 0.02 | -3.56 | 583074.00% |
| NCEL | NewcelX Ltd. | $3.54 | 1.59M | — | — | — | — | -0.65 | 0.91 | — | 0.11 | — |
| VRAX | Virax Biolabs Group Limit… | $0.21 | 918.76K | +63,388% | +84% | — | +77,309% | -0.50 | 0.53 | 478.92 | 0.14 | -9595.00% |
| XRTX | XORTX Therapeutics Inc. | $2.26 | 629.39K | — | — | — | — | -0.75 | 0.97 | — | -0.37 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.09) − 1 = — (DCF, example).